β Spotlight on ISCL Board Member Youn H. Kim, MD
Dr. Kim, the Joanne and Peter Haas Jr. Professor at Stanford, directs the Multidisciplinary Cutaneous Lymphoma Clinic. A leader in CTCL research, she has advanced clinical trials, biomarkers, and novel therapies.
π med.stanford.edu/profiles/y...
10.11.2025 13:00 β π 0 π 0 π¬ 0 π 0
Spotlight on ISCL Board Member Dr. Pablo L. Ortiz-Romero, MD, PhD β Professor and Head of Dermatology at Hospital 12 de Octubre, Universidad Complutense de Madrid. A leader in CTCL research, he pioneers CTCL care in Spain, conducts European trials, and serves on the ISCL and EORTC CLTG boards.
06.11.2025 17:59 β π 0 π 0 π¬ 0 π 0
Spotlight on ISCL Board Member Dr. Christiane Querfeld, MD, PhD β Professor and Director, Cutaneous Lymphoma Program, City of Hope. Expert in CTCL, immune checkpoints, and immunotherapy. Passionate about research, patients, mentoring, and exploring the world.
π www.cityofhope.org/patients...
05.11.2025 17:39 β π 0 π 0 π¬ 0 π 0
Spotlight on ISCL Board Member Dr. Yang Wang, MD, PhD β Chair and Professor of Dermatology at Peking University First Hospital, Beijing. Passionate physician-scientist and award-winning researcher, she built Chinaβs largest CTCL cohort and national registry. π www.researchgate.net/profile/Yang...
30.10.2025 12:45 β π 0 π 0 π¬ 0 π 0
Oleg Akilov, MD, PhD | Department of Dermatology | University of Pittsburgh
Spotlight on ISCL Board Member Dr. Oleg E. Akilov, MD, PhD: Associate Professor of Dermatology at the University of Pittsburgh and Director of the Cutaneous Lymphoma Program. Dr. Akilov advances precision medicine and fosters international collaboration. Learn more: www.dermatology.pitt.edu/pe...
24.10.2025 17:51 β π 0 π 0 π¬ 0 π 0
πSpotlight on ISCL Treasurer Dr. Ivan Litvinov
Associate Professor of Dermatology at McGill University, he leads research in cutaneous lymphoma/oncology and care for Northern Indigenous communities. He is currently involved in organizing the 6th WCCL in Montreal.
π www.mcgill.ca/expmed/dr-iva...
22.10.2025 11:50 β π 1 π 0 π¬ 0 π 0
Prof. Dr. Rudolf Stadler, Head of Dermatopathology at Ruhr University Bochum, is a leader in dermato-oncology and CTCL research. Former EORTC CTCL chair and German Dermatological Society president, he advances lymphoma therapy and fosters global collaboration through ISCL.
21.10.2025 11:50 β π 0 π 0 π¬ 0 π 0
6wccl |
π£ Submit your abstract & register for the 6th WCCL in MontrΓ©al! Share research through oral or poster presentations β with opportunities for young investigators.
π
Key Dates:
- Opens: Oct 16, 2025
- Submission Deadline: Jan 23, 2026
- Notification: Feb 24, 2026
- Registration due: Mar 17, 2026
16.10.2025 12:00 β π 1 π 0 π¬ 0 π 0
Steven M. Horwitz
I am a medical oncologist who focuses on the care of patients with lymphoma, and I have clinical expertise in all types of lymphomas. My research is aimed at developing an improved understanding of new therapies for patients with several less-common
π Spotlight on ISCL Secretary Dr. Steven Horwitz
Dr. Steven Horwitz, Attending Physician at Memorial Sloan Kettering Cancer Center and Professor at Weill Cornell, specializes in T-cell lymphomas. His research advances targeted and immunotherapeutic treatments.
π www.mskcc.org/cancer-care/d...
14.10.2025 12:00 β π 0 π 0 π¬ 0 π 0
π Spotlight on ISCL President Dr. Julia Scarisbrick π
Consultant dermatologist & Professor at the University of Birmingham, she leads global cutaneous lymphoma research, co-leads the PROCLIPI study, and is dedicated to improving patient survival & quality of life.
π www.birmingham.ac.uk/staff/...
25.09.2025 16:25 β π 0 π 0 π¬ 0 π 0
Save the date for the 6th World Congress of Cutaneous Lymphomas (6WCCL), June 25β27, 2026. Hosted by ISCL, USCLC & EORTC CLTG. Featuring leading research, lectures, and abstracts on all aspects of cutaneous lymphomas. More info: 6wccl.org
15.09.2025 11:00 β π 0 π 0 π¬ 0 π 0
Inaugural Chair, Department of Global & Public Health, McGill University. Canada Research Chair in Epidemiology & Global Health
Tweets: own views. He/him.
https://en.wikipedia.org/wiki/Madhukar_Pai
We're the UKβs only charity dedicated to lymphoma - the most common blood cancer. We're here to inform, support and connect.
Find out more: https://lymphoma-action.org.uk/
Haemato-oncologist. Clinical researcher. Mostly lymphoma and phase 1 haematology studies.
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
Lymphoma & partic CNSL, TCL & immunodeficiency
UCLH/UCL (no medical advice)
views my own
The Video Journal of Hematology & Hematological Oncology is dedicated to providing up-to-date information & international expertiseπ©Έπ₯ ποΈ #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma
Doctor for lymphoma patients, researcher, collaborator, professor/division director @Perlmutter_CC @nyulangone Posts mine RT not=endorsement, he/him/his
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology.
The worldβs leading professional organization representing more than 50,000 oncology professionals caring for people with cancer.
FGB promotes therapeutic innovation from the earliest phases of research and the education of new generations of physician-scientists in Oncology
European Research Council, set up by the EU, funds top researchers of any nationality, helping them pursue great ideas at the frontiers of knowledge. #HorizonEU
The National Non-Hodgkin Lymphoma Audit(NNHLA) is part of the National Cancer Audit Collaborating Centre.
NNHLA evaluates the patterns of care and outcomes for patients with Non-Hodgkin Lymphoma in England and Wales. #bloodcancer #cancerresearch #lymphoma
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia.
A leading center for expert, compassionate cancer care and advanced research.
Appts: 877-442-3324 | http://dana-farber.org
8 Research groups
120+ Staff members
750+ Issued publications
60+ Awarded PhD degrees
www.ior.usi.ch
Based in Bellinzona (Switzerland), IOR is affiliated to @usi.ch and member of Bios+ (www.biosplus.ch).
Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma
Oncologist and lymphoma specialist. National Clinical Director for cancer at NHSE. Chair, Cancer Goal, Office for Life Sciences. University of Southampton.
Stem cell and cancer biologist | Hofschneider Professor and Group Leader at the Institute of Oncology Research (IOR), Switzerland
www.baggiolinilab.org
We pioneer next-generation immunotherapy by blocking pro-tumoral immune activity. Our research uncovers how tumor cells, microbiota, and immune infiltrates drive hormone-dependent and BRCA-mutated cancers.
https://ior.usi.ch/group/cancer-immunotherapy